Amyloid β-induced neuronal hyperexcitability triggers progressive epilepsy

Journal of Neuroscience

Volumn 29, Issue 11, 2009, Pages 3453-3462

  Minkeviciene, Rimante ^a   Rheims, Sylvain ^c   Dobszay, Marton B ^c   Zilberter, Misha ^e   Hartikainen, Jarmo ^a   Fülöp, Lívia ^f   Penke, Botond ^g   Zilberter, Yuri ^d,e   Harkany, Tibor ^e,h   Pitkänen, Asia ^a,b   Tanila, Heikki ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c AIX MARSEILLE UNIVERSITY   (France)

^d INSERM   (France)

^e KAROLINSKA INSTITUTE   (Sweden)

^f Department of Medical Chemistry ^*

^g UNIVERSITY OF SZEGED   (Hungary)

^h UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[25-35]; CALBINDIN; NEUROPEPTIDE Y; OLIGOMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APPSWE GENE; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; ELECTROENCEPHALOGRAM; ELECTROPHYSIOLOGY; EPILEPSY; EPILEPTIC DISCHARGE; EXCITATORY POSTSYNAPTIC POTENTIAL; GENE; GRAND MAL SEIZURE; IMMUNOREACTIVITY; MALE; MEMBRANE DEPOLARIZATION; MEMBRANE STEADY POTENTIAL; MOSSY FIBER; MOUSE; NEOCORTEX; NERVE CELL EXCITABILITY; NONHUMAN; PATCH CLAMP; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PS1DE9 GENE; PYRAMIDAL NERVE CELL; WILD TYPE;

EID: 63849180498     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5215-08.2009     Document Type: Article

References (48)

1. Amatniek JC, Hauser WA, DelCastillo-Castaneda C, Jacobs DM, Marder K, Bell K, Albert M, Brandt J, Stern Y (2006) Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia 47:867-872.
2. Babic T, Zurak N (1999) Convulsions induced by donepezil. J Neurol Neurosurg Psychiatry 66:410.
3. Breteler MM, Claus JJ, van Duijn CM, Launer LJ, Hofman A (1992) Epidemiology of Alzheimer's disease. Epidemiol Rev 14:59-82.
4. Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, Staufenbiel M, Konnerth A, Garaschuk O (2008) Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 321:1686-1689.
5. Carlson GA, Borchelt DR, Dake A, Turner S, Danielson V, Coffin JD, Eckman C, Meiners J, Nilsen SP, Younkin SG, Hsiao KK (1997) Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice. Hum Mol Genet 611:1951-1959.
6. Cavazos JE, Golarai G, Sutula TP (1991) Mossy fiber synaptic reorganization induced by kindling: time course of development, progression, and permanence. J Neurosci 11:2795-2803.
7. Chin J, Palop JJ, Yu GQ, Kojima N, Masliah E, Mucke L (2004) Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice. J Neurosci 24:4692-4697.
8. Del Vecchio RA, Gold LH, Novick SJ, Wong G, Hyde LA (2004) Increased seizure threshold and severity in young transgenic CRND8 mice. Neurosci Lett 367:164-167.
9. Diez M, Danner S, Frey P, Sommer B, Staufenbiel M, Wiederhold KH, Hökfelt T (2003) Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing b-amyloid precursor protein (APP) with the Swedish double mutation (APP23). Neurobiol Dis 14:579-594.
10. Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, Engel J Jr (2005) Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46:470-472.
11. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373:523-527.
12. Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, Prada C, Greenberg SM, Bacskai BJ, Frosch MP (2006) Characterization of amyloid deposition in the APPswe/PSldE9 mouse model of Alzheimer disease. Neurobiol Dis 24:516-524.
13. Götz J, Streffer JR, David D, Schild A, Hoerndli F, Pennanen L, Kurosinski P, Chen F (2004) Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy. Mol Psychiatry 9:664-683.
14. Greenberg SM, Tennis MK, Brown LB, Gomez-Isla T, Hayden DL, Schoenfeld DA, Walsh KL, Corwin C, Daffner KR, Friedman P, Meadows ME, Sperling RA, Growdon JH (2000) Donepezil therapy in clinical practice: a randomized crossover study. Arch Neurol 57:94-99.
15. Harkany T, O'Mahony S, Kelly JP, Soos K, Toro I, Penke B, Luiten PG, Nyakas C, Gulya K, Leonard BE (1998) Beta-amyloid(Phe (SO3H)24)25-35 in rat nucleus basalis induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation. Behav Brain Res 90:133-145.
16. Hauser WA, Morris ML, Heston LL, Anderson VE (1986) Seizures and myoclonus in patients with Alzheimer's disease. Neurology 36:1226-1230.
17. Hesdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA (1996) Dementia and adult-onset unprovoked seizures. Neurology 46:727-730.
18. Hof PR, Young WG, Bloom FE, Belichenko PV, Celio MR (2000) Comparative cytoarchitechtonic atlas of the C57BL/6 and 129/Sv mouse brains. Amsterdam: Elsevier.
19. Hsiao KK, Borchelt DR, Olson K, Johannsdottir R, Kitt C, Yunis W, Xu S, Eckman C, Younkin S, Price D, ladecola C, Clark HB, Carlson G (1995) Age-related CNS disorder and early death in transgenic FVB/N mice over-expressing Alzheimer amyloid precursor proteins. Neuron 15:1203-1218.
20. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, Younkin SG, Borchelt DR (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13:159-170.
21. Knobloch M, Farinelli M, Konietzko U, Nitsch RM, Mansuy IM (2007) Aβ oligomermediated long-term potentiation impairment involves protein phosphatase 1-dependent mechanisms. J Neurosci 27:7648-7653.
22. Kobayashi DT, Chen KS (2005) Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease. Genes Brain Behav 4:173-196.
23. Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, Sun X, Frosch MP, Selkoe DJ (2003) Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40:1087-1093.
24. Lima PA, Vicente MI, Alves FM, Dionisio JC, Costa PF (2008) Insulin increases excitability via a dose-dependent dual inhibition of voltage-activated K+ currents in differentiated NlE-115 neuroblastoma cells. Eur J Neurosci 27:2019-2032.
25. Lozsadi DA, Lamer AJ (2006) Prevalence and causes of seizures at the time of diagnosis of probable Alzheimer's disease. Dement Geriatr Cogn Disord 22:121-124.
26. Mendez MF, Catanzaro P, Doss RC, Arguello R, Frey WH 2nd (1994) Seizures in Alzheimer's disease: clinicopathologic study. J Geriatr Psychiatry Neurol 7:230-233.
27. Minkeviciene R, Ihalainen J, Malm T, Matilainen O, Keksa-Goldsteine V, Goldsteins G, Iivonen H, Leguit N, Glennon J, Koistinaho J, Banerjee P, Tanila H (2008) Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wildtype mice. J Neurochem 105:584-594.
28. Misonou H, Mohapatra DP, Trimmer JS (2005) Kv2.1: a voltage-gated K+ channel critical to dynamic control of neuronal excitability. NeuroToxicology 26:743-752.
29. Nissinen J, Lukasiuk K, Pitkänen A (2001) Is mossy fiber sprouting present at the time of the first spontaneous seizures in rat experimental temporal lobe epilepsy? Hippocampus 11:299-310.
30. Oksman M, Iivonen H, Hogyes E, Amtul Z, Penke B, Leenders I, Broersen L, Lütjohann D, Hartmann T, Tanila H (2006) Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol Dis 23:563-572.
31. Olafsson E, Ludvigsson P, Gudmundsson G, Hesdorffer D, Kjartansson O, Hauser WA (2005) Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurol 4:627-634.
32. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L (2007) Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 55:697-711.
33. + current. Neurobiol Aging 27:1673-1683.
34. Price DL, Sisodia SS, Borchelt DR (1998) Genetic neurodegenerative diseases: the human illness and transgenic models. Science 282:1079-1083.
35. Racine RJ (1972) Modification of seizure activity by electrical stimulation II. Motor seizures. Electroencephalogr Clinl Neurophysiol 32:281-294.
36. Rheims S, Minlebaev M, Ivanov A, Represa A, Khazipov R, Holmes GL, Ben-Ari Y, Zilberter Y (2008) Excitatory GABA in rodent developing neocortex in vitro. J Neurophysiol 100:609-619.
37. Shemer I, Holmgren C, Min R, Fülöp L, Zilberter M, Sousa KM, Farkas T, Härtig W, Penke B, Burnashev N, Tanila H, Zilberter Y, Harkany T (2006) Non-fibrillar betaamyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors. Eur J Neurosci 23:2035-2047.
38. Sloviter RS (1982) A simplified Timm stain procedure compatible with formaldehyde fixation and routine paraffin embedding of rat brain. Brain Res Bull 8:771-774.
39. Sorvari H, Soininen H, Pitkänen A (1996) Calbindin-D28K- immunoreactive cells and fibres in the human amygdaloid complex. Neuroscience 75:421-443.
40. Szegedi V, Juhász G, Rózsa E, Juhász-Vedres G, Datki Z, Fülöp L, Bozsó Z, Lakatos A, Laczkó I, Farkas T, Kis Z, Tóth G, Soós K, Zarándi M, Budai D, Toldi J, Penke B (2006) Endomorphin-2, an endogenous tetrapeptide, protects against Abetal-42 in vitro and in vivo. FASEB J 20:1191-1193.
41. Talley EM, Sirois JE, Lei Q, Bayliss DA (2003) Two-pore-domain (KCNK) potassium channels: dynamic roles in neuronal function. Neuroscientist 9:46-56.
42. Tauck DL, Nadler JV (1985) Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats. J Neurosci 5:1016-1022.
43. Tonder N, Kragh J, Bolwig T, Zimmer J (1994) Transient decrease in calbindin immunoreactivity of the rat fascia dentata granule cells after repeated electroconvulsive shocks. Hippocampus 4:79-83.
44. Tyzio R, Ivanov A, Bernard C, Holmes GL, Ben-Ari Y, Khazipov R (2003) Membrane potential of CA3 hippocampal pyramidal cells during postnatal development. J Neurophysiol 90:2964-2972.
45. Vezzani A, Sperk G, Colmers WF (1999) Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci 22:25-30.
46. Wang Q, Rowan MJ, Anwyl R (2007) β-Amyloid-mediated inhibition of NMDA receptor-dependent long-term potentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide. J Neurosci 24:6049-6056.
47. + currents in neocortical cultures. Neurobiol Dis 13:177-190.
48. Zarándi M, Soós K, Fülöp L, Bozsó Z, Datki Z, Tóth GK, Penke B (2007) Synthesis of Abeta[l-42] and its derivatives with improved efficiency. J Pept Sci 13:94-99.